Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FQAJN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,339
Award facts
- Contract value 100% obligated
- $8,339.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,339.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 120 tablets of Xtandi 40 mg on September 12, 2025, with an ultimate completion date of September 15, 2025. This award was made without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its location in Park Ridge, IL 60068. Xtandi is an oral pharmaceutical treatment commonly used in oncology applications, reflecting the company's established role supplying specialized prescription medications to federal healthcare systems.
This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This overarching contract vehicle enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, including branded and generic prescription drugs, biologics, and medical consumables. The contractor's federal procurement portfolio demonstrates consistent success competing in the pharmaceutical supply sector without set-aside restrictions, leveraging its woman-owned small business status to secure contracts that support the Department of Defense healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FQAJN?
SPE2DB25FQAJN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FQAJN worth?
The government has obligated $8,339 on SPE2DB25FQAJN.
Is contract SPE2DB25FQAJN an order under another contract?
Yes. SPE2DB25FQAJN is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAJN competed?
The extent of competition for SPE2DB25FQAJN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award